You are here

Callitas Health Inc.

Listing Exchange: 
CSE
Status: 
Suspended
Industry: 
Life Sciences
Symbol: 
LILY
CSE Index: 
Currency: 

You are here

Callitas Health Inc. (LILY)

SEDAR Information

Company Info

Address
734-1055 Dunsmuir Street
Vancouver, BC V7X 1B1
Canada
Email
bkeane@callitas.com
Website
http://www.callitas.com
Listing date
Wednesday, January 28, 2015
Transfer Agent
TSX Trust Company
Email
bkeane@callitas.com
Auditor
Davidson & Company LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
32,462,095
Reserved for Issuance: 
0

Company Officers

James M. Thompson, President & Chief Executive Officer
Brian Keane, CEO

Bulletins

11/07/2019

2019-0711 - Suspension - Callitas Health Inc. (LILY)

Le 11 juillet/July 2019

Callitas Health Inc. is in default of CSE requirements. Effective immediately, Callitas Health will be suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.  A cease trade order has been issued by the Ontario Securities Commission and British Columbia Securities Commission.

_______________________________

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-08-11_TechTues_MedicalDevices_Website

Tech Tuesdays

Tuesday, August 11, 2020 -
4:15pm to 5:00pm
08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm